- Home
- Publications
- Publication Search
- Publication Details
Title
MiRNAs-mediated cisplatin resistance in breast cancer
Authors
Keywords
miRNAs, Cisplatin, Drug resistance, Breast
Journal
TUMOR BIOLOGY
Volume 37, Issue 10, Pages 12905-12913
Publisher
Springer Nature
Online
2016-07-22
DOI
10.1007/s13277-016-5216-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Breast cancer statistics, 2015: Convergence of incidence rates between black and white women
- (2015) Carol E. DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells
- (2015) Lina Yang et al. CANCER LETTERS
- Mitochondrial Transcription Factor A and Mitochondrial Genome as Molecular Targets for Cisplatin-Based Cancer Chemotherapy
- (2015) Kimitoshi Kohno et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Deciphering the BRCA1 Tumor Suppressor Network
- (2015) Qinqin Jiang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- miR-141 confers docetaxel chemoresistance of breast cancer cells via regulation of EIF4E expression
- (2015) YA-SAI YAO et al. ONCOLOGY REPORTS
- Role of miR-155 in drug resistance of breast cancer
- (2015) Dan-dan Yu et al. TUMOR BIOLOGY
- The clinicopathological significance and drug target potential of FHIT in breast cancer, a meta-analysis and literature review
- (2015) Junming Xu et al. Drug Design Development and Therapy
- in vitro Modulation of P-glycoprotein, MRP-1 and BCRP Expression by Mangiferin in Doxorubicin-Treated MCF-7 Cells
- (2014) Melva Louisa et al. Asian Pacific Journal of Cancer Prevention
- Copy Number Gain of hsa-miR-569 at 3q26.2 Leads to Loss of TP53INP1 and Aggressiveness of Epithelial Cancers
- (2014) Pradeep Chaluvally-Raghavan et al. CANCER CELL
- Oncogenic KRAS Confers Chemoresistance by Upregulating NRF2
- (2014) S. Tao et al. CANCER RESEARCH
- microRNA-200a Inhibits Cell Proliferation by Targeting Mitochondrial Transcription Factor A in Breast Cancer
- (2014) Jia Yao et al. DNA AND CELL BIOLOGY
- Roles of the WWOX in pathogenesis and endocrine therapy of breast cancer
- (2014) Juan Li et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- DNA damage responsive microRNAs misexpressed in human cancer modulate therapy sensitivity
- (2014) Marijn T.M. van Jaarsveld et al. Molecular Oncology
- MiR-218 regulates cisplatin chemosensitivity in breast cancer by targeting BRCA1
- (2014) Xiao He et al. TUMOR BIOLOGY
- Hsp90 inhibition by PU-H71 induces apoptosis through endoplasmic reticulum stress and mitochondrial pathway in cancer cells and overcomes the resistance conferred by Bcl-2
- (2013) Cindy Gallerne et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- External Qi of Yan Xin Qigong Inhibits Activation of Akt, Erk/12 and NF-ĸB and Induces Cell Cycle Arrest and Apoptosis in Colorectal Cancer Cells
- (2013) Xin Yan et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Role of the Nrf2-ARE Pathway in Liver Diseases
- (2013) Sang Mi Shin et al. Oxidative Medicine and Cellular Longevity
- Concordant and Discordant Regulation of Target Genes by miR-31 and Its Isoforms
- (2013) Yu-Tzu Chan et al. PLoS One
- microRNAs as Mediators of Drug Toxicity
- (2012) Tsuyoshi Yokoi et al. Annual Review of Pharmacology and Toxicology
- Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients
- (2012) Heidi Schwarzenbach et al. BREAST CANCER RESEARCH AND TREATMENT
- Clinical significance of mitochondrial transcription factor A expression in patients with colorectal cancer
- (2012) Yoshifumi Nakayama ONCOLOGY REPORTS
- Microarray-Assisted Pathway Analysis Identifies MT1X & NFκB as Mediators of TCRP1-Associated Resistance to Cisplatin in Oral Squamous Cell Carcinoma
- (2012) Bo Peng et al. PLoS One
- Purification and biochemical characterization of a novel protein—tongue cancer chemotherapy resistance-associated protein1 (TCRP1)
- (2012) Bo Peng et al. PROTEIN EXPRESSION AND PURIFICATION
- Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse
- (2011) J. Chuck Harrell et al. BREAST CANCER RESEARCH AND TREATMENT
- Micro-RNA expression in cisplatin resistant germ cell tumor cell lines
- (2011) Matthias Port et al. Molecular Cancer
- ATR mediates cisplatin resistance in a p53 genotype-specific manner
- (2011) N Sangster-Guity et al. ONCOGENE
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Molecular Stratification of Triple-Negative Breast Cancers
- (2011) C. M. Perou ONCOLOGIST
- MicroRNA signature of cis-platin resistant vs. cis-platin sensitive ovarian cancer cell lines
- (2011) Smriti Kumar et al. Journal of Ovarian Research
- MicroRNA-mediated drug resistance in breast cancer
- (2011) Kristy R. Kutanzi et al. Clinical Epigenetics
- Cisplatin resistance: Preclinical findings and clinical implications
- (2010) Beate Köberle et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- MicroRNA and drug resistance
- (2010) J Ma et al. CANCER GENE THERAPY
- A MicroRNA Targeting Dicer for Metastasis Control
- (2010) Graziano Martello et al. CELL
- Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin
- (2010) Igor P. Pogribny et al. INTERNATIONAL JOURNAL OF CANCER
- DNA-SCARS: distinct nuclear structures that sustain damage-induced senescence growth arrest and inflammatory cytokine secretion
- (2010) F. Rodier et al. JOURNAL OF CELL SCIENCE
- Deconstructing the molecular portraits of breast cancer
- (2010) Aleix Prat et al. Molecular Oncology
- A Systematic Review of Genes Involved in the Inverse Resistance Relationship Between Cisplatin and Paclitaxel Chemotherapy: Role of BRCA1
- (2009) Britta Stordal et al. CURRENT CANCER DRUG TARGETS
- DNA Damage, Aging, and Cancer
- (2009) Jan H.J. Hoeijmakers NEW ENGLAND JOURNAL OF MEDICINE
- Mechanisms of Chemotherapeutic Drug Resistance in Cancer Therapy—A Quick Review
- (2009) Fu-Shing Liu Taiwanese Journal of Obstetrics & Gynecology
- MicroRNA Microarray Identifies Let-7i as a Novel Biomarker and Therapeutic Target in Human Epithelial Ovarian Cancer
- (2008) N. Yang et al. CANCER RESEARCH
- MicroRNA Expression Profiling in Human Ovarian Cancer: miR-214 Induces Cell Survival and Cisplatin Resistance by Targeting PTEN
- (2008) H. Yang et al. CANCER RESEARCH
- MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth
- (2008) Julia Schultz et al. CELL RESEARCH
- Increased expression of Nrf2/ARE-dependent anti-oxidant proteins in tamoxifen-resistant breast cancer cells
- (2008) Sang Kyum Kim et al. FREE RADICAL BIOLOGY AND MEDICINE
- Antiproliferative Effects by Let-7 Repression of High-Mobility Group A2 in Uterine Leiomyoma
- (2008) Y. Peng et al. MOLECULAR CANCER RESEARCH
- The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
- (2008) Philip A. Gregory et al. NATURE CELL BIOLOGY
- Genetic disruption of the Nrf2 compromises cell-cycle progression by impairing GSH-induced redox signaling
- (2008) N M Reddy et al. ONCOGENE
- Suppression of non-small cell lung tumor development by the let-7 microRNA family
- (2008) M. S. Kumar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The microRNA-200 Family Regulates Epithelial to Mesenchymal Transition
- (2008) Emily L. Paterson et al. TheScientificWorldJOURNAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started